Intraosseous Infusion Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Intraosseous Infusion Kits Market is segmented by Device Technology (Battery Powered, Manual, Impact Driven), Route of Administration (Distal Femur, Sternum, Distal and Proximal Tibia, Other Routes of Administration), End Users (Hospitals, Ambulatory Surgical Centers, Other End Users), and Geography.

Market Snapshot

Intraosseous Infusion Kits Market overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.2 %
Intraosseous Infusion Kits Market Major Companies

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The intraosseous infusion kits market is anticipated to register a CAGR of nearly 7.2%, during the forecast period.

  • Certain factors that are driving the market growth include increasing cases of trauma and arthritis, along with the advantages over other routes of drug administrations.
  • Intraosseous infusion plays a significant role in the treatment of osteoarthritis. Over the past few years, a technique of platelet-rich plasma (PRP) infiltration for the treatment of severe hip osteoarthritis has been being studied. The technique involves a combined intra-articular and intraosseous infiltration of PRP to reach all joint tissues, especially the subchondral bone, and hence facilitate a greater distribution of PRP.
  • In the United Kingdom general practice, around 1% of people age 45 years or more recently have been clinically diagnosed with knee Osteo-Arthritis and 5% have a previously-made diagnosis of OA in another joint (S Vijayan et al, 2015).
  • According to the Arthritis Foundation, in 2017, it was estimated that more than half of the Australians were found to have osteoarthritis in the age group of 25 to 64 years. About 10% of the Chinese population is suffering from degenerative joint disease. All these factors are driving the market growth across the world.

Scope of the Report

Intraosseous Infusion refers to a fast and effective way of getting critical fluids and medications into the vascular system. While Intravenous (IV) access uses a peripheral vein, Intraosseous Infusion (IO) accesses the venous system through the bone marrow. The devices and kits used for this procedure are termed as intraosseous infusion kits.

By Device Technology
Battery Powered
Impact Driven
By Route of Administration
Distal Femur
Distal and Proximal Tibia
Other Routes of Administration
By End Users
Ambulatory Surgical Centers
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Sternum Shows Lucrative Growth Opportunity in the Global Intraosseous Infusion Kits Market

  • Sternal Intraosseous Infusion (IO) is considered one of the fastest and most convenient ways to access the vascular system and swiftly deliver emergency fluids and medication through the manubrium in the sternum.
  • Since people belonging to certain professions, such as the military, need an intraosseous infusion route and device that would enable them to get critical fluids and medications into the bloodstream as quickly and reliably as possible, hence the sternal route is preferred.
  • A number of recent clinical evidence indicates the sternal route for intraosseous infusion improves patient outcomes. Therefore, this segment is expected to grow at a significant rate over the forecast period.
Intraosseous Infusion Kits Market Trends

North America Dominates the Global Intraosseous Infusion Kits Market

· The United States had the most significant share of the autologous matrix-induced chondrogenesis market in North America, due to the increasing incidence of bone and joint disorders, along with the rising geriatric and obese population.

· As per the latest 2018 data published by the American Orthopedic Society for Sports Medicine, approximately 3.5 million athletes are receiving medical treatment due to sports injuries every year in the United States.

· Furthermore, increasing physician and patient awareness about newly introduced treatment procedures and technologies along with the substantial investments by the government for the technologies adopted for easy and rapid drug administration is supporting the growth of the market in North America.

Intraosseous Infusion Kits Market Growth Rate

Competitive Landscape

The market is competitive and consists of a few major players. As far as recent developments are concerned, in March 2019, PAVmed Inc. announced that its PortIO Intraosseous Infusion System, which consists of an implantable intraosseous vascular access device and insertion kit, was able to achieve a maintenance-free implant duration of over 60 days in pre-clinical animal testing. Companies, like Aero Healthcare, Becton, Dickinson and Company, Biopsybell, Cook Medical, PAVmed Inc., Persys Medical, Pyng Medical, and Teleflex Inc., hold the substantial market share in the market.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Cases of Trauma and Arthritis

      2. 4.2.2 Advantages over Other Route of Drug Administrations

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost associated with Procedure

      2. 4.3.2 Pain, Side Effects, and Complications Associated with Intraosseous Infusion

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Device Technology

      1. 5.1.1 Battery Powered

      2. 5.1.2 Manual

      3. 5.1.3 Impact Driven

    2. 5.2 By Route of Administration

      1. 5.2.1 Distal Femur

      2. 5.2.2 Sternum

      3. 5.2.3 Distal and Proximal Tibia

      4. 5.2.4 Other Routes of Administration

    3. 5.3 By End Users

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Aero Healthcare

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Biopsybell

      4. 6.1.4 Cook Medical

      5. 6.1.5 PAVmed Inc.

      6. 6.1.6 Persys Medical

      7. 6.1.7 Pyng Medical

      8. 6.1.8 Teleflex Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Intraosseous Infusion Kits Market market is studied from 2018 - 2026.

The Intraosseous Infusion Kits Market is growing at a CAGR of 7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Pyng Medical , Biopsybell, Cook Medical , PAVmed Inc. , Persys Medical are the major companies operating in Intraosseous Infusion Kits Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!